Eμ-Crlf2/Jak2 mutant B-ALL cells that had remained viable even weeks after knockdown of Jak2 in vivo retained leukemogenic potential and remained partially sensitive to Jak2 depletion, as shown by serial transplant experiments. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.